The statement of the Polish Society of Allergology regarding necessary changes in therapeutic program of severe IgE-mediated allergic asthma with omalizumab.
Zbigniew Bartuzi, Anna Bodzenta-Łukaszyk, Piotr Kuna, Izabela Kupryś-Lipińska, Ewa Niżankowska-Mogilnicka, Bolesław Samoliński
求助PDF
{"title":"The statement of the Polish Society of Allergology regarding necessary changes in therapeutic program of severe IgE-mediated allergic asthma with omalizumab.","authors":"Zbigniew Bartuzi, Anna Bodzenta-Łukaszyk, Piotr Kuna, Izabela Kupryś-Lipińska, Ewa Niżankowska-Mogilnicka, Bolesław Samoliński","doi":"10.5603/PiAP.2015.0053","DOIUrl":null,"url":null,"abstract":"335 Address for correspondence: Prof. Piotr Kuna, MD, PhD, Department of Internal Medicine Asthma and Allergy Medical University of Lodz, ul. 22 Kopcinskiego 22, 90-153 Lodz, Poland, e-mail: piotr.kuna@umed.lodz.pl DOI: 10.5603/PiAP.2015.0053 Received: 13.06.2015 Copyright © 2015 PTChP ISSN 0867–7077 Zbigniew Bartuzi, Anna Bodzenta-Łukaszyk, Piotr Kuna, Izabela Kupryś-Lipinska, Ewa Nizankowska -Mogilnicka, Boleslaw Samolinski Department of Allergology, Clinical Immunology and Internal Medicine Collegium Medicum University of Mikolaj Kopernik, Torun, Poland Department of Allergology and Internal Medicine Medical in Bialystok, Poland Department of Internal Medicine, Asthma and Allergy, University Hospital N. Barlicki, Łodź, Poland Pulmonology Clinic, Jagiellonian University, Collegium Medicum, Krakow, Poland Department of Prophylaxis of Environmental Threats and Allergology, Medical University in Warsaw, Poland","PeriodicalId":20258,"journal":{"name":"Pneumonologia i alergologia polska","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pneumonologia i alergologia polska","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/PiAP.2015.0053","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4
引用
批量引用
Abstract
335 Address for correspondence: Prof. Piotr Kuna, MD, PhD, Department of Internal Medicine Asthma and Allergy Medical University of Lodz, ul. 22 Kopcinskiego 22, 90-153 Lodz, Poland, e-mail: piotr.kuna@umed.lodz.pl DOI: 10.5603/PiAP.2015.0053 Received: 13.06.2015 Copyright © 2015 PTChP ISSN 0867–7077 Zbigniew Bartuzi, Anna Bodzenta-Łukaszyk, Piotr Kuna, Izabela Kupryś-Lipinska, Ewa Nizankowska -Mogilnicka, Boleslaw Samolinski Department of Allergology, Clinical Immunology and Internal Medicine Collegium Medicum University of Mikolaj Kopernik, Torun, Poland Department of Allergology and Internal Medicine Medical in Bialystok, Poland Department of Internal Medicine, Asthma and Allergy, University Hospital N. Barlicki, Łodź, Poland Pulmonology Clinic, Jagiellonian University, Collegium Medicum, Krakow, Poland Department of Prophylaxis of Environmental Threats and Allergology, Medical University in Warsaw, Poland
波兰过敏症学会关于使用omalizumab治疗严重ige介导的过敏性哮喘的必要改变的声明。
本文章由计算机程序翻译，如有差异，请以英文原文为准。
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
